Iqra holds a MSc in Cellular and Molecular Medicine from the
University of Ottawa in Ottawa, Canada. She also holds a BSc in Life
Sciences from Queen’s University in Kingston, Canada. Currently, she
is completing a PhD in Laboratory Medicine and Pathobiology from
the University of Toronto in Toronto, Canada. Her research has
ranged from across various disease areas including Alzheimer’s
disease, myelodysplastic syndrome, bleeding disorders and rare
pediatric brain tumors.
Gilenya (fingolimod) is an effective treatment for relapsing-remitting multiple sclerosis (RRMS) in everyday clinical practice, a new study shows. The therapy was shown to be effective even in patients switching ... Read more
Clene Nanomedicine says its pre-clinical studies demonstrate the remyelination effects of CNM-Au8, supporting its potential to treat multiple sclerosis (MS) and other demyelinating disorders. Clene presented its data in ... Read more
A global collaboration of researchers led by Belgium’s Flanders Institute for Biotechnology has determined the structure of the pro-inflammatory cytokine IL-23 and its receptor IL-23R, which could be potential ... Read more
Multiple sclerosis patients should be routinely assessed for chronic and, especially, neuropathic pain in order to properly diagnose and treat this condition, which appears to directly affect the degree ... Read more
Available long-term data on Fampyra (fampridine; 4-aminopyridine) suggest the treatment may improve walking speed in patients with multiple sclerosis (MS) for up to one year, but more research is needed, a ... Read more
Atara Biotherapeutics has started a Phase 1 clinical trial to assess ATA188’s safety and potential to treat progressive or relapsing-remitting multiple sclerosis.
ATA188 is the company’s next-generation T-cell immunotherapy. It targets Epstein-Barr ... Read more
Opioid growth factor (OGF) can serve as a new biomarker to determine diagnosis and progression of multiple sclerosis (MS), say researchers at Pennsylvania State University. Their study, “Serum -enkephalin levels ... Read more
Two researchers at the University of Tasmania’s Menzies Institute for Medical Research have received an innovative multiple sclerosis research fellowship that was created to drive basic scientific research into ... Read more
British military personnel are at significantly higher risk of dying from multiple sclerosis than people in other occupations, a study reports.
University of Southampton researchers had done a previous study ... Read more
An Italian study recently found that Multiple sclerosis patients in the first year of diagnosis frequently suffer from depression, pre-morbid personality, self-perception issues and other psychological problems. Yet, it ... Read more
Patients with secondary progressive multiple sclerosis (SPMS) have a higher burden of illness than patients with relapsing-remitting multiple sclerosis, a new study showed. The study, “Characteristics, burden of illness, ... Read more